High materiality8/10
Biodesix (BDSX) PT Raised to $27 at Canaccord
Why it may matterVerify against the original reporting
Bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Canaccord Genuity raises BDSX target to $27; Posted price $15.22; priceChangeSinceSignal +10.45.
- Target $27; price $15.22; +10.45 since signal.
Key facts
- 01
Target: $27
- 02
Posted price: $15.22
- 03
Analyst firm: Canaccord Genuity
- 04
Analyst: Kyle Mikson
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.